Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A platform-independent AI tumor lineage and site (ATLAS) classifier.
Rydzewski NR, Shi Y, Li C, Chrostek MR, Bakhtiar H, Helzer KT, Bootsma ML, Berg TJ, Harari PM, Floberg JM, Blitzer GC, Kosoff D, Taylor AK, Sharifi MN, Yu M, Lang JM, Patel KR, Citrin DE, Sundling KE, Zhao SG. Rydzewski NR, et al. Among authors: citrin de. Commun Biol. 2024 Mar 13;7(1):314. doi: 10.1038/s42003-024-05981-5. Commun Biol. 2024. PMID: 38480799 Free PMC article.
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, Sarkaria JN, Sondel PM, Tran PT, Wilson GD, Willers H, Wong RKS, Harari PM. Bristow RG, et al. Lancet Oncol. 2018 May;19(5):e240-e251. doi: 10.1016/S1470-2045(18)30096-2. Lancet Oncol. 2018. PMID: 29726389 Review.
A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy.
Patel KR, Rowe LS, Schott E, Cooley-Zgela T, Ning H, Turkbey B, Choyke P, Lindenberg L, Mena E, Pinto PA, Zhang Q, Shih J, Salerno KE, Citrin DE. Patel KR, et al. Among authors: citrin de. Adv Radiat Oncol. 2022 Jul 15;7(6):101024. doi: 10.1016/j.adro.2022.101024. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420197 Free PMC article.
A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer.
Patel KR, Rydzewski NR, Schott E, Cooley-Zgela T, Ning H, Cheng J, Salerno K, Huang EP, Pinto PA, Lindenberg L, Mena E, Choyke P, Turkbey B, Citrin DE. Patel KR, et al. Among authors: citrin de. Pract Radiat Oncol. 2023 Nov-Dec;13(6):540-550. doi: 10.1016/j.prro.2023.05.012. Epub 2023 Jul 11. Pract Radiat Oncol. 2023. PMID: 37442430 Free article. Clinical Trial.
A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy.
Patel KR, Rydzewski NR, Schott E, Cooley-Zgela T, Ning H, Cheng J, Salerno K, Huang EP, Lindenberg L, Mena E, Choyke P, Turkbey B, Citrin DE. Patel KR, et al. Among authors: citrin de. Int J Radiat Oncol Biol Phys. 2024 Feb 29:S0360-3016(24)00323-7. doi: 10.1016/j.ijrobp.2024.02.014. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38428681 Free article.
Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancer.
Salerno KE, Turkbey B, Lindenberg L, Mena E, Schott EE, Brennan AK, Roy S, Shankavaram U, Patel K, Cooley-Zgela T, McKinney Y, Wood BJ, Pinto PA, Choyke P, Citrin DE. Salerno KE, et al. Among authors: citrin de. Brachytherapy. 2022 Jul-Aug;21(4):442-450. doi: 10.1016/j.brachy.2022.03.009. Epub 2022 May 4. Brachytherapy. 2022. PMID: 35523680 Free PMC article.
134 results